We have determined the mutation in a child with partial adenosine deaminase (ADA) deficiency who is phenotypically homozygous for a mutant ADA gene encoding a heat-labile enzyme (Am. J. Hum. . Sequencing of cDNA demonstrated a C to A transversion that results in the replacement of a proline by a glutamine residue at codon 297. As this mutation generated a new recognition site in exon 10 of genomic DNA for the enzyme Alu I, Southern blot analysis was used to establish that this child was indeed homozygous for the mutation. The abnormal restriction fragment generated by this mutation was also found in a second partially ADA-deficient patient who phenotypically is a genetic compound and also expresses a heat-labile ADA (in addition to a more acidic than normal ADA) (Am. J. Hum. Genet. 38:13-25). Sequencing of cDNA clones from the second patient established the identical codon 297 mutation. Transfection of the mutant cDNA into heterologous cells resulted in expression of a heat-labile ADA of normal electrophoretic mobility and isoelectric point, properties exhibited by the ADA in the patients' cells.
Introduction
Mutations at the adenosine deaminase (ADA)' locus that diminish enzyme activity result in three overlapping phenotypes. Those mutations that result in virtually complete loss of enzyme activity in all cell types cause a rapidly fatal, infantile onset syndrome of severe combined immunodeficiency (SCID). In contrast, mutations that abolish enzyme activity in erythrocytes but allow expression of variable residual ADA in other cell types (partial ADA deficiency), are usually associated with normal immunologic function. However, at least two patients with partial ADA deficiency have presented with a late onset immunodeficiency syndrome (reviewed in Reference 1). Additionally, we have previously reported an apparently increased prevalence of partial ADA deficiency in popu- 1 . Abbreviations used in this paper: ADA, adenosine deaminase; RFLP, restriction fragment length polymorphism; SCID, severe combined immunodeficiency.
lations derived from the Caribbean, that phenotypically does not appear to be due to the spread of a single mutation (2) . To further elucidate the molecular basis for this clustering of partial ADA deficiency among individuals from the Caribbean as well as for the clinical heterogeneity, we have sought to define the mutant genes and examine their function in vitro. From sequence analysis of cDNA we have now determined the mutation in a partially ADA-deficient child from Santo Domingo who phenotypically appears to be homozygous for a mutant ADA gene coding for an enzyme that is labile at febrile temperatures (2) . The single base substitution found resulted in an abnormal restriction fragment, which enabled us to determine that a second unrelated partially ADA-deficient child carried the same mutation.
Methods Materials
Cell lines from the two partially ADA-deficient children (GM 6142 and 6143A) were obtained from the National Institutes of Health Genetic Mutant Repository, Camden, NJ. Both children were ascertained by the New York State Newborn Screening Program for ADA deficiency and determined to be partially ADA deficient (2, unpublished observations). The parents of both children came from Santo Domingo, but they were not related and did not have last names in common.
Methods for analysis ofDNA and RNA Isolation of DNA and RNA, electrophoresis in agarose gels, Southern and Northern blotting, and hybridization with radiolabeled cDNA probes were performed as we have previously described by essentially standard methods (3, 4) . An ADA cDNA containing the complete coding sequence and extending from the Nae I site to the 3' Nco I site was used as probe (5) . For delineation of the abnormal restriction fragment generated by the exon 10 mutation, a cDNA fragment (Bgl II/Pst I) spanning exons 9-1 1 was used (6) . RNA was extracted from normal and mutant lymphoid B cell lines by the method ofChirgwin et al. (7) as described by Adrian et al. (8) and mRNA was isolated by binding to and elution from oligo dT columns (4) . Analysis of the structural integrity of mRNA was assessed by sensitivity of mRNAcDNA hybrids to digestion with S I nuclease, essentially as described by Adrian (8) , based on the methods ofFavaloro (9) . The probe used was a 1.45-kb single-stranded M 13 clone containing the entire ADA cDNA antisense coding sequences and extending from the Nae I site to an Nco I site in the 3' untranslated sequence (5) .
The cDNA libraries were constructed in lambda gt 11 (10) essentially as described by Gubler and Hoffman (1 1) . Primary platings of library cDNA were screened using randomly labeled ADA cDNA probes (4, 12) . cDNA inserts were subcloned into M 13 mp 19 or pUC 19 for the DNA sequence analysis using a series of ADA-specific primers (13-15).
and Hinf I to release a 1.125-kb fragment containing the complete coding sequences and extending from 1 bp before the initiation ATG to 31 bp 3' of the stop codon (5, 6) . The 3' recessed ends were filled in using the Klenow fragment of DNA polymerase, ligated to phosphorylated Hind III linkers, and digested with Hind III. The cDNA fragment was isolated after electrophoresis in 1% low melt agarose and ligated into a unique Hind III site of the expression vector pSV2-Hind III (5) . A clone was chosen in which the orientation of the cDNA was correct, the plasmid was amplified, and DNA was purified by centrifugation in cesium chloride (4) .
Expression in heterologous cells and analysis ofproperties of the expressed ADA. Cos I monkey kidney cells were grown to confluency in DME supplemented with 10% FCS, trypsinized, diluted to 0.5 X 106 cells/100-mm2 petri dish, and grown overnight. The cells were transfected with 15 ,ug of plasmid DNA per petri by calcium phosphate precipitation as previously described ( 16) and 8 h later briefly exposed to 16 .7% glycerol. Cells were grown for a total of 48 h from the time of transfection, rinsed, harvested by scraping, and lysed by brief sonication. The 10,000 g supernatant was analyzed for human ADA activity after electrophoresis in starch gel or isoelectric focusing as previously described (2, 17) .
Stable transformants were isolated after transfection of mouse 3T3 cells with 0.5 Mg of pBR-Neo together with the ADA plasmid. Clones expressing the Neo gene (G418 resistant), were selected as we have previously described (16) . 10 G418-resistant clones analyzed all expressed human ADA. For studies of heat stability, cells from a 75-cm2 flask were resuspended in 40 ,l 0.01 M phosphate buffer, pH 7.5, briefly sonicated, one-half ofa 10,000 g supernatant placed at 56°C for 15 min, and ADA activity visualized after electrophoresis in starch gel (2, 17) . 
Results
Gross structure ofthe mutant ADA gene. Table  I ). The mRNA was normal in size and abundance. In addition, no digestion of mRNA-cDNA hybrids by S1 nuclease was observed (not shown). Sequence of the mutant ADA and detection of the same mutation in a second patient. To determine the molecular defect in this patient, ADA cDNA clones derived from immortalized B cells were studied. Complete sequencing of a fulllength cDNA clone revealed only a C to A transversion at nucleotide 890 (A of the initiation ATG = 1) (Fig. 1) . The same base substitution was found in two additional cDNA clones. Two of the three clones began 30 bp upstream of the previously reported site ofinitiation (20, 21) . This replacement results in the substitution of a glutamine for a proline residue in codon 297 (6) .
The base substitution predicts the generation of a new site for the enzyme Alu I in exon 10, which should result in loss of a 0.585-kb fragment and appearance of smaller 0.321-and 0.264-kb fragments (22) as detected by a Bgl II/Pst I cDNA probe spanning exons 9-1 1. Analysis of genomic DNA from GM 6142 digested with Alu I revealed loss of an -0.6-kb fragment and appearance of a smaller fragment (Fig. 2) . The loss of the 0.6-kb fragment and concomitant appearance of an abnormal fragment is consistent with homozygosity for this mutation.
We next sought to determine if any additional partially ADA-deficient individuals, particularly those exhibiting a heat-labile enzyme, also exhibited this abnormal Alu I fragment. One other partially ADA-deficient child (GM 6143 A) who is a genetic compound expressing a heat-labile ADA and an acidic ADA (1) also showed a smaller abnormal Alu I fragment with approximately half the intensity ofthat seen in GM (2) . Family studies (data not shown) confirm that the Pst I RFLP in GM 6143 is on the chromosome bearing a different mutation.
Comparison ofthe properties ofthe cloned and endogenous mutant ADA. To determine if the isolated mutant cDNA coded for an enzyme with the properties of the mutant ADA expressed in the lymphoid cells of the patients, we inserted the coding portions of the cDNA into an SV40-derived expression vector and transiently expressed the mutant cDNA in COS 1 monkey kidney cells. The ADA transiently expressed by the cloned ADA cDNA had a normal mobility after electrophoresis in starch gel and a normal pI (not shown), properties exhibited by the enzyme found in the cells of these patients (2) . To study heat stability of the mutant enzyme under more physiologic conditions, we next isolated stable transformants expressing the mutant ADA. The pSV2 ADA was cotransfected into mouse 3T3 fibroblasts with a pSV neo plasmid specifying the dominant selectable Neo gene and stable transformants expressing human ADA isolated. The ADA expressed by the stable transformants exhibited the same normal electrophoretic mobility as the transiently expressed ADA and was labile to heat, as was the mutant ADA in the patients' cells (Fig. 3) .
Discussion
Six different mutations at the ADA locus have previously been precisely defined in children with ADA deficiency and SCID (13, [24] [25] [26] [27] . We now report the first definition of a mutation that results in partial ADA deficiency in two unrelated children, both of whom express a heat-labile mutant ADA either alone or in combination with a second mutant ADA. The mutation is a C to A transversion at bp 890 and results in the replacement of a hydrophobic proline by a polar glutamine residue at codon 297. The substitution occurs at a boundary between a turn and a beta configuration in the predicted secondary structure (6) and predicts a modest increase in hydrophylicity extending from a transition of a turn to a beta configuration and into the hydrophobic region ofthe beta configuration (Table II; [28] [29] [30] , consistent with the increased lability to heat observed for this mutant enzyme (2) . The mutation occurs seven codons preceeding a mutation in the same exon 10 detected in a patient with ADA-SCID (25) . This latter mutation results in replacement of a hydrophobic leucine by the basic amino acid arginine at codon 304. According to the predicted secondary structure, the two different mutations occur at either side of a seven-amino acid stretch with a beta configuration. Both represent loss of hydrophobic amino acids, but in the case of the mutation resulting in total deficiency of ADA and SCID the replacement is by a very polar basic amino acid that is predicted to result in a major increase in hydrophylicity (26) (27) (28) , extending back into the beta structure and altering the site of transition to a turn. We have previously reported that there is an apparent increased prevalence of partial ADA deficiency in the Caribbean (2) that did not appear to reflect the spread ofa single mutation due to "founder effect" combined with a high coefficient of inbreeding. Thus we defined at least six different mutations in six of these children on the basis of characterization of the mutant ADAs (2, 31, 32) . We have now unambiguously demonstrated that there are indeed different mutations in this population, since we have identified one mutation that is present in two unrelated partially ADA-deficient children from the Caribbean but not in any of the other partially ADA-deficient children. One child is homozygous for the mutation while the second child is a genetic compound carrying a second mutation. Both children are unrelated, but since both derive from Santo Domingo it is likely that they represent descendants of a common ancestor carrying the mutation. In support of a common progenitor, the children showed the same changes at multiple polymorphic sites. However, since the haplotype on which this mutation occurs in both children is very common (-60%), there is still a substantial chance that the mutations occurred independently on different chromosomes not distinguishable by available markers (13, 18, 19, 24 
